121
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Novozyme 435-Catalyzed Efficient Acylation of 3-n-Butylphthalide in Organic Medium

, , , &
Pages 376-388 | Received 18 Aug 2007, Accepted 17 Sep 2007, Published online: 18 Sep 2008
 

Abstract

Novozyme 435 could catalyze efficient acylation of 3-n-butylphthalide in organic medium. The conversion of 3-n-butylphthalide increased with the increase of hydrophobicity of solvent below that of hexane. The more available solvent was hexane. Salt hydride could control fixed water activity. The optimum water activity was 0.62. And the optimum of reaction time, velocity of agitation, dosage of Novozyme 435 and acetic anhydride to 3-n-butylphtrhalide molar ratio were 48 hours, 150 rpm, 8 mg/mL and 8:1, respectively. The conversion of 48.9% could be obtained at a water activity of 0.62 in hexane. Furthermore, Novozyme 435 had an enantioselective acylation of racemic 3-n-butylphthalide by original analysis.

ACKNOWLEDGMENTS

We thank Shijiazhuang Pharma group 3-n-butylphthalide pharmaceutical Co., Ltd, China for their gift of 3-n-butylphthalide and Amano Enzyme Inc. for their kind gifts of PS, PS-C, AK and AY. We also thank Ministry of Education, P.R.China for financial supports in the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, IRT0532) and the financial supports of the National “973” plan (2003CB716008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.